What is Ardent Health Partners's revenue?

Ardent Health Partners (ARDT) generated $6.4B in revenue over the trailing twelve months, up 6.7% year over year.

Is Ardent Health Partners profitable?

Ardent Health Partners reported $134.3M in net income over the trailing twelve months, a 2.1% net margin.

What is Ardent Health Partners's earnings per share?

Ardent Health Partners's diluted EPS over the trailing twelve months is $0.95.

Where does Ardent Health Partners's income statement data come from?

Every line is extracted from Ardent Health Partners's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Ardent Health Partners ARDT Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$6.43B+6.7%	$6.32B+6.0%	$6.33B+10.9%	$6.2B+10.0%	$6.02B+8.9%
Total cost of revenue	$162.49M+10.4%	$155.7M+6.4%	$152.52M+5.6%	$150.14M+4.9%	$147.14M+4.0%
Gross profit	$6.27B+6.6%	$6.17B+6.0%	$6.17B+11.0%	$6.05B+10.2%	$5.88B+9.0%
Gross margin	97.5%-0.1pp	97.5%0.0pp	97.6%+0.1pp	97.6%+0.1pp	97.6%+0.1pp
General and administrative	$154.5M+15.0%	$140.8M+6.3%	$140.7M+9.8%	$137.9M+11.8%	$134.4M+11.1%
Compensation and benefits	$2.66B+3.5%	$2.66B+4.9%	$2.66B+7.3%	$2.62B+7.3%	$2.57B+6.5%
Professional fees	$1.23B+10.4%	$1.19B+8.7%	$1.17B+8.7%	$1.14B+8.6%	$1.11B+10.1%
Depreciation and amortization	$162.49M+10.4%	$155.7M+6.4%	$152.52M+5.6%	$150.14M+4.9%	$147.14M—
Impairment charges	——	$0—	$0—	$0—	$0—
Other operating expenses	$681.69M+34.9%	$647.31M+30.4%	$634.55M+36.6%	$553.53M+17.4%	$505.15M+8.6%
Total costs & expenses	$6.14B+8.8%	$6.04B+7.8%	$5.96B+8.4%	$5.78B+6.2%	$5.64B+5.4%
Interest expense	$53.24M-12.0%	$55.2M-15.8%	$56.35M-20.1%	$57.06M-23.8%	$60.49M-19.8%
Other income (expense), net	-$5.18M-224%	-$5.23M-200%	$3.41M—	$3.74M—	$4.18M—
Net investment gains (losses)	$7.93M-83.3%	$23.32M-11.2%	$46.52M+1,020%	$46.73M+3,372%	$47.55M+2,851%
Income before income taxes	$286.75M-24.7%	$286.36M-21.1%	$361.23M+76.5%	$420.5M+117%	$380.69M+112%
Income tax expense	$57.09M-15.9%	$56.22M-11.3%	$64.47M—	$78.94M—	$67.87M—
Net income	$134.28M-40.2%	$135.81M-35.4%	$205.06M+113%	$254.86M+181%	$224.68M+178%
Net margin	2.1%-1.6pp	2.1%-1.4pp	3.2%+1.6pp	4.1%+2.5pp	3.7%+2.3pp
Net income attributable to noncontrolling interests	$95.38M+8.2%	$94.32M+5.5%	$91.71M+18.2%	$86.7M+14.4%	$88.14M+18.7%
Diluted earnings per share	$0.95-42.8%	$0.96-39.2%	$1.48—	$1.84—	$1.66—
Basic earnings per share	$0.94-44.0%	$0.96-39.6%	$1.50—	$1.86—	$1.68—
Weighted-average shares, diluted	566M+5.4%	564.9M+8.1%	556.2M+7.8%	552.5M+9.5%	537.1M+6.5%
Weighted-average shares, basic	563.6M+5.2%	562.4M+7.8%	554.1M+7.5%	550M+9.0%	535.7M+6.2%
Depreciation and amortization	$162.49M+10.4%	$155.7M+6.4%	$152.52M+5.6%	$150.14M+4.9%	$147.14M+4.0%
Share-based compensation expense related to employee stock plans	$38.96M—	$39.29M—	——	——	——
Amortization Of Financing Costs And Discounts	$3.95M-25.1%	$4.38M-19.9%	$4.8M-3.1%	$5.09M+1.6%	$5.28M—
Amortization of capitalized software and acquired intangible assets	——	$800K—	——	——	——
Capital investments accrued but not yet paid	$10.64M-27.8%	$16.37M+76.5%	$17.24M+97.0%	$17.62M+43.1%	$14.74M—
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	$114.65M-10.9%	$152.82M+21.7%	$52.66M-55.6%	$212.45M—	$128.64M—
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$127.9M-38.9%	$122.46M-39.2%	$192.94M—	$237.45M—	$209.34M—
Less: comprehensive income attributable to noncontrolling interest	$95.38M+8.2%	$94.32M+5.5%	$91.71M+18.2%	$86.7M+14.4%	$88.14M+18.7%
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	$223.28M-24.9%	$216.79M-25.5%	$284.64M+86.7%	$324.16M+112%	$297.49M+101%
Guarantor fixed charge ratio	——	——	——	——	——
Guarantor net leverage ratio	——	——	——	——	——
Minimum portfolio coverage ratio	——	——	——	——	——
Federal	——	$6.1M-80.0%	$12.21M-52.5%	$18.33M-12.2%	$24.44M+52.5%
Current State And Local Tax Expense Benefit	——	$6.53M-31.3%	$7.28M-17.4%	$8.02M-1.0%	$8.77M+18.5%
Federal	——	$36.74M+67.2%	$33.04M+84.3%	$29.35M+111%	$25.66M+160%
Deferred taxes	$45.11M+115%	$43.59M+87.3%	$36.48M—	$21.47M—	$21.02M—
Deferred income taxes	——	$43.59M+81.3%	$38.71M+103%	$33.82M+141%	$28.93M+221%
State	——	$6.86M+421%	$5.47M+658%	$4.09M+3,093%	$2.7M+680%
Defined Contribution Plan Cost Recognized	$52.5M+1.2%	$51.6M+2.2%	$54.6M+17.4%	$53.3M+16.9%	$51.9M+15.6%
Depreciation, depletion, and amortization including finance leases	——	$154.9M+5.9%	$152.75M+5.4%	$150.6M+4.9%	$148.45M+4.4%
Effective tax rates	$1.98—	$1.97—	——	——	——
Income taxes at U.S. statutory rate of 21%	——	——	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	——	——	——	——
Executive and equity-based compensation limitations	——	——	——	——	——
Executive and equity-based compensation limitations	——	$4.68M+31.9%	$4.39M+62.3%	$4.11M+120%	$3.83M+272%
Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent	——	——	——	——	——
Nontaxable or nondeductible items	——	——	——	——	——
State income taxes – net of federal income tax benefit	——	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——	——
Effective Income Tax Rate Reconciliation, Tax Credit, Percent	——	——	——	——	——
Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount	——	——	——	——	——
Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount	——	——	——	——	——
Gain Loss On Sale Of Previously Unissued Stock By Subsidiary Or Equity Investee Nonoperating Income	——	——	——	-$740K-125%	-$3.29M—
General Insurance Expense	$192.3M+4.2%	$194.6M+5.9%	$189.6M+9.0%	$187.1M+11.8%	$184.5M+11.7%
Goodwill Additions	——	$27.37M+271%	$22.37M+304%	$17.37M+371%	$12.38M+571%
Federal taxes	——	$24M-26.4%	$26.15M-6.4%	$28.3M+21.5%	$30.45M+63.3%
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	——	$0—	$0—	$0—	$0—
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	——	$60.14M-21.1%	$64.16M-1.5%	$68.19M+26.2%	$72.22M+68.2%
Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount	——	$19.76M+9.2%	$19.35M+11.4%	$18.93M+13.8%	$18.51M+16.4%
Nontaxable or Nondeductible items	——	$899K-44.5%	$1.08M-34.3%	$1.26M-24.3%	$1.44M-14.5%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	——	-$1.54M-3,555%	-$1.16M-7,141%	-$788.5K-1,151%	-$415.25K-411%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	——	$12.19M+24.9%	$11.58M+38.3%	$10.97M+57.1%	$10.37M+85.0%
Changes in unrecognized tax benefits	——	$0+100%	-$2.3M+65.8%	-$4.61M-7.8%	-$6.91M-283%
Accrued tax refund receivable	——	——	——	——	——
Tax refund receivable	$100K-75.0%	$2.1M+163%	-$1.7M—	-$100K—	$400K—
Income Taxes Paid, Net	——	$36.51M-12.2%	$37.78M+4.8%	$39.06M+28.0%	$40.33M+61.5%
Increase (Decrease) in Accounts Receivable	-$89.9M—	-$59.16M—	——	——	——
Accrued compensation	——	——	——	——	——
Increase (Decrease) in Inventories	——	——	——	——	$14.15M—
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	$94.56M—	$62.06M—	——	——	——
Increase (Decrease) in Prepaid Expense and Other Assets	$241.36M—	$126.18M—	$166.27M—	——	——
Increase in professional fees and general liability reserves	——	$51.3M—	——	——	——
Insurance Financing Arrangements, Principal Payments	$14.79M+24.1%	$15.04M+44.0%	$13.82M-3.7%	$12.64M-28.6%	$11.92M—
Lease Cost	——	$262.49M+3.8%	$260.07M+3.8%	$257.65M+3.9%	$255.23M+3.9%
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders	——	——	——	$80.72M+26.7%	$77.84M+18.7%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$101.42M—	-$103.47M—	——	——	——
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$219.01M-3.3%	-$214.23M+2.8%	-$233.45M-35.9%	-$219.32M-44.3%	-$211.94M—
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$435.08M+42.7%	$470.51M+49.4%	$366.64M+39.4%	$301.98M+15.3%	$304.93M—
Net Income Loss Attributable To Noncontrolling Interest	$95.38M+8.2%	$94.32M+5.5%	$91.71M+18.2%	$86.7M+14.4%	$88.14M+18.7%
Net Income (Loss) Attributable to Nonredeemable Noncontrolling Interest	-$98.95M-6.0%	-$96.73M-1.3%	-$95.59M-13.4%	-$92.12M-13.5%	-$93.35M-17.8%
Proceeds from the sale of noncontrolling interest	——	——	——	——	——
Number of hospitals	——	——	——	——	52.5—
Number of managed hospitals	——	——	——	——	——
Number of operating segments	——	——	——	——	——
Number of rehabilitation hospitals	——	——	——	——	3.5—
Number of reportable segments	——	——	——	——	1.8—
Number of surgical hospitals	——	——	——	——	3.5—
Operating Lease Payments	——	$201.41M+2.0%	$200.41M+1.5%	$199.42M+1.0%	$198.43M+0.5%
Other Comprehensive Income Loss Before Tax	-$8.63M+59.1%	-$18.06M-47.1%	-$16.74M+27.7%	-$23.89M-84.9%	-$21.09M-476%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax	-$8.63M+59.1%	-$18.06M-47.1%	-$16.74M+27.7%	-$23.89M-84.9%	-$21.09M-476%
Other comprehensive income (loss)	-$6.37M+59.1%	-$13.35M-47.1%	-$12.37M+27.7%	-$17.66M-84.9%	-$15.59M-476%
Tax expense (benefit)	-$2.25M+59.1%	-$4.71M-47.1%	-$4.37M+27.7%	-$6.24M-85.0%	-$5.51M-476%
Membership and other income	$111.05M+1.2%	$119.38M+12.0%	$112.53M+9.7%	$110.35M+17.3%	$109.75M+16.7%
All other operating activities	——	——	——	——	——
Other revenue, percentage of revenue	6.9%-0.6%	7.5%+0.1%	7.4%+0.1%	7.4%+0.6%	7.5%+0.6%
Payment for (Proceeds from) Other Investing Activity	-$580K-130%	-$179K-110%	$1.06M+20.3%	$2.03M+784%	$1.92M+345%
Payments for (Proceeds from) Productive Assets	$217.08M+16.4%	$211.9M+13.0%	$209.18M+27.8%	$193.85M+33.5%	$186.58M—
Payments to Noncontrolling Interests	$90.31M+16.0%	$88.24M+21.1%	$82.08M+23.7%	$80.72M+26.7%	$77.84M—
Percentage of revenue	400%0.0%	400%0.0%	400%0.0%	400%0.0%	400%0.0%
Proceeds from insurance financing arrangements	——	——	——	——	$21.76M—
Proceeds from revolver	——	$0—	$0-100%	$0-100%	$0-100%
Financing — other	-$5.18M-224%	-$5.23M-200%	$3.41M—	$3.74M—	$4.18M—
Professional fees and general liability losses	——	——	——	——	——
Repayments of Lines of Credit	——	$0—	$0-100%	$0-100%	$0-100%
Repayments of Long-Term Debt	$10.24M-90.4%	$7.99M-92.6%	$6.54M-94.0%	$6.42M-94.2%	$106.21M—
Change in estimated implicit price concessions	——	$486.1M-27.3%	$531.65M-22.2%	$577.2M-17.4%	$622.75M-12.7%
Risk-free rate	——	——	——	——	——
Expected dividend rate	——	——	——	——	——
Weighted-average volatility	——	——	——	——	——
Short Term Lease Cost	——	$25.49M+5.6%	$25.15M+7.2%	$24.81M+8.9%	$24.47M+10.6%
New issues (in shares)	——	——	——	——	——
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment	——	——	——	——	——
Issuance of vested restricted stock units	$52K—	$5K—	——	——	——
Stock Option Plan Expense	$38.96M+45.8%	$39.29M+119%	$39.29M+334%	$37.75M+3,332%	$26.73M—
Value of shares repurchased	——	$3.15M—	——	——	——
Supplies Expense	$1.09B+5.6%	$1.08B+4.8%	$1.07B+5.0%	$1.05B+2.9%	$1.03B+2.4%
Net income (loss)	$3.81M-26.9%	$2.65M-56.9%	$3.88M-41.9%	$5.42M+0.9%	$5.21M+4.4%
Variable Lease Cost	——	$33.97M+18.9%	$32.62M+18.9%	$31.27M+19.0%	$29.92M+19.0%
Add: dilutive effect of potential common shares (in shares)	——	——	——	——	$870.45K+1,042%
Worker's compensation benefit (cost)	——	——	——	——	——
EBIT	$339.99M-22.9%	$341.56M-20.3%	$417.58M+51.8%	$477.57M+77.9%	$441.19M+73.3%
EBITDA	$502.48M-14.6%	$497.26M-13.5%	$570.1M+35.9%	$627.7M+52.5%	$588.33M—
EBITDA	$502.48M-14.6%	$497.26M-13.5%	$570.1M+35.9%	$627.7M+52.5%	$588.33M—
EBITDA margin	7.8%-2.0pp	7.9%-1.8pp	9%+1.7pp	10.1%+2.8pp	9.8%—
EBIT	$339.99M-22.9%	$341.56M-20.3%	$417.58M+51.8%	$477.57M+77.9%	$441.19M+73.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Ardent Health Partners.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ardent Health Partners's revenue?: Ardent Health Partners (ARDT) generated $6.4B in revenue over the trailing twelve months, up 6.7% year over year.
Is Ardent Health Partners profitable?: Ardent Health Partners reported $134.3M in net income over the trailing twelve months, a 2.1% net margin.
What is Ardent Health Partners's earnings per share?: Ardent Health Partners's diluted EPS over the trailing twelve months is $0.95.
Where does Ardent Health Partners's income statement data come from?: Every line is extracted from Ardent Health Partners's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.